Department of Critical Care Medicine, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Department of Laboratory Medicine, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Crit Care. 2018 Sep 29;22(1):241. doi: 10.1186/s13054-018-2178-7.
Preparing an antibiotic stewardship program requires detailed information on overall antibiotic use, prescription indication and ecology. However, longitudinal data of this kind are scarce. Computerization of the patient chart has offered the potential to collect complete data of high resolution. To gain insight in our global antibiotic use, we aimed to explore antibiotic prescription in our intensive care unit (ICU) from various angles over a prolonged time period.
We studied all adult patients admitted to Ghent University Hospital ICU from 1 January 2013 until 31 December 2016. Antibiotic prescription data were prospectively merged with diagnostic (suspected focus, severity and probability of infection at the time of prescription, or prophylaxis) and microbiology data by ICU physicians during daily workflow through dedicated software. Definite focus of infection and probability of infection (classified as high/moderate/low) were reassessed by dedicated ICU physicians at patient discharge.
During the study period, 8763 patients were admitted and overall antibiotic consumption amounted to 1232 days of therapy (DOT)/1000 patient days. Antibacterial DOT (84% of total DOT) were linked with infection in 80%; the predominant foci were the respiratory tract (49%) and the abdomen (19%). A microbial cause was identified in 56% (3169/5686). Moderate/low probability infections accounted for 42% of antibacterial DOT prescribed for respiratory tract infections; for abdominal infections, this figure was 15%. The median treatment duration of moderate/low probability respiratory infections was 4 days (IQR 3-7). Antifungal DOT (16% of total DOT) were linked with infection in 47% of total antifungal DOT. Antifungal prophylaxis was primarily administered in the surgical ICU (76%), with a median duration of 4 DOT (IQR 2-9).
By prospectively combining antibiotic, microbiology and clinical data we were able to construct a longitudinal, multifaceted dataset on antibiotic use and infection diagnosis. A complete overview of this kind may allow the identification of antibiotic prescription patterns that require future antibiotic stewardship attention.
制定抗生素管理计划需要详细了解总体抗生素使用情况、处方指征和抗生素的生态学情况。然而,此类纵向数据非常有限。患者病历的计算机化提供了收集高分辨率完整数据的潜力。为了深入了解我们的整体抗生素使用情况,我们旨在从多个角度探索一个较长时间段内重症监护病房(ICU)的抗生素处方情况。
我们研究了 2013 年 1 月 1 日至 2016 年 12 月 31 日期间入住根特大学医院 ICU 的所有成年患者。抗生素处方数据由 ICU 医生在日常工作流程中通过专用软件与诊断(疑似感染灶、感染严重程度和感染可能性,或预防用药)和微生物学数据进行前瞻性合并。在患者出院时,由专门的 ICU 医生重新评估明确的感染灶和感染可能性(分为高/中/低)。
在研究期间,共收治 8763 例患者,抗生素治疗总天数为 1232 天(每 1000 个患者日 12.32 天)。抗菌药物治疗天数(总治疗天数的 84%)中有 80%与感染有关;主要感染灶为呼吸道(49%)和腹部(19%)。在 5686 例(56%)中确定了微生物病因。中度/低度感染可能性的呼吸道感染的抗菌药物治疗天数占抗菌药物治疗总天数的 42%;腹部感染的这一比例为 15%。中度/低度感染可能性的呼吸道感染的中位治疗时间为 4 天(IQR 3-7)。抗真菌药物治疗天数(总治疗天数的 16%)中有 47%与真菌感染有关。预防性使用抗真菌药物主要在外科 ICU(76%),中位治疗天数为 4 天(IQR 2-9)。
通过前瞻性地合并抗生素、微生物学和临床数据,我们构建了一个关于抗生素使用和感染诊断的纵向、多方面的数据集。这种全面的概述可能有助于确定需要未来抗生素管理关注的抗生素处方模式。